Marshall Wace

Marshall Wace’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Marshall Wace’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$461K	Buy
2022 Q2	–	Sell
2022 Q1	$3.86M	Buy
2015 Q2	–	Sell
2015 Q1	$513K	Buy